• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何提高对多重耐药菌携带者风险患者的医院入院筛查:一项前后干预研究和成本效益分析。

How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis.

机构信息

Nursing Department, Quality of care, University Hospitals of Geneva, Geneva, Switzerland

Quality of Care Service, University Hospitals of Geneva, Geneva, Switzerland.

出版信息

BMJ Open Qual. 2022 Apr;11(2). doi: 10.1136/bmjoq-2021-001699.

DOI:10.1136/bmjoq-2021-001699
PMID:35483731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9052048/
Abstract

BACKGROUND

Infection prevention and control (IPC) is a prioritised task for healthcare workers in emergency department (ED). Here, we examined compliance with admission screening (AS) and additional precautions (AP) measures for patients at risk of infection with multidrug-resistant organisms (MDROs) by using a two-stage, multifaceted educational intervention, also comparing the cost of a developed automated indicator for AS and AP compliance and clinical audits to sustain observed findings.

METHODS

In the first stage, staff in the ED of the University Hospitals of Geneva, Switzerland, were briefed on IPC measures (AS and AP). A cross-sectional survey was then conducted to assess barriers to IPC measures. In the second stage, healthcare workers underwent training sessions, and an electronic patient record 'order-set' including AS and AP compliance indicators was designed. We compared the cost-benefit of the audits and the automated indicators for AS and AP compliance.

RESULTS

Compliance significantly improved after training, from 36.2% (95% CI 23.6% to 48.8%) to 78.8% (95% CI 67.1% to 90.3%) for AS (n=100, p=0.0050) and from 50.2% (95% CI 45.3% to 55.1%) to 68.5% (95% CI 60.1% to 76.9%) for AP (n=125, p=0.0092). Healthcare workers recognised MDRO screening as an ED task (70.2%), with greater acknowledgment of risk factors at AS considered an ED duty. The monthly cost was higher for clinical audits than the automated indicator, with a reported yearly cost of US$120 203. The initial cost of developing the automated indicator was US$18 290 and its return on investment US$3.44 per US$1 invested.

CONCLUSION

Training ED staff increased compliance with IPC measures when accompanied by team discussions for optimal effectiveness. An automated indicator of compliance is cheaper and closer to real-time than a clinical audit.

摘要

背景

感染预防与控制(IPC)是急诊科医护人员的首要任务。在这里,我们通过两阶段、多方面的教育干预措施,检查了对感染多重耐药菌(MDRO)风险患者的入院筛查(AS)和附加预防措施(AP)措施的依从性,并比较了为 AS 和 AP 依从性和临床审计开发的自动化指标的成本,以维持观察到的结果。

方法

在第一阶段,瑞士日内瓦大学医院的急诊科工作人员接受了 IPC 措施(AS 和 AP)的培训。然后进行了横断面调查,以评估 IPC 措施的障碍。在第二阶段,医护人员接受了培训课程,并设计了一个包含 AS 和 AP 依从性指标的电子病历“医嘱集”。我们比较了审计和自动化指标在 AS 和 AP 依从性方面的成本效益。

结果

培训后,AS 的依从性从 36.2%(95%CI 23.6%至 48.8%)显著提高到 78.8%(95%CI 67.1%至 90.3%)(n=100,p=0.0050),AP 的依从性从 50.2%(95%CI 45.3%至 55.1%)显著提高到 68.5%(95%CI 60.1%至 76.9%)(n=125,p=0.0092)。医护人员将 MDRO 筛查视为急诊科任务(70.2%),并认为在 AS 时更应认识到危险因素。与自动化指标相比,临床审计的每月成本更高,报告的年成本为 120203 美元。开发自动化指标的初始成本为 18290 美元,投资回报率为每投资 1 美元 3.44 美元。

结论

培训急诊科工作人员并辅以团队讨论以提高 IPC 措施的依从性,可实现最佳效果。与临床审计相比,依从性的自动化指标更便宜且更接近实时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b15/9052048/d41fefead4e4/bmjoq-2021-001699f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b15/9052048/d41fefead4e4/bmjoq-2021-001699f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b15/9052048/d41fefead4e4/bmjoq-2021-001699f01.jpg

相似文献

1
How to improve hospital admission screening for patients at risk of multidrug-resistant organism carriage: a before-and-after interventional study and cost-effectiveness analysis.如何提高对多重耐药菌携带者风险患者的医院入院筛查:一项前后干预研究和成本效益分析。
BMJ Open Qual. 2022 Apr;11(2). doi: 10.1136/bmjoq-2021-001699.
2
Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics.瑞士伴侣动物诊所中较差的感染预防和控制标准与耐碳青霉烯肠杆菌科和其他多药耐药菌的环境污染有关。
Antimicrob Resist Infect Control. 2020 Jun 23;9(1):93. doi: 10.1186/s13756-020-00742-5.
3
Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study.发展中国家一家三级医院儿科患者入院时携带多药耐药菌(MDRO)的流行情况及相关危险因素。一项横断面研究。
BMC Infect Dis. 2021 Jun 9;21(1):547. doi: 10.1186/s12879-021-06275-5.
4
Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.由对多重耐药菌进行主动筛查和针对性控制措施组成的两级感染控制管理策略的成本及可能的益处。
J Hosp Infect. 2016 Jun;93(2):191-6. doi: 10.1016/j.jhin.2016.02.013. Epub 2016 Mar 3.
5
Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO).多药耐药菌自动风险评估系统(autoRAS-MDRO)的开发与评估。
J Hosp Infect. 2018 Feb;98(2):202-211. doi: 10.1016/j.jhin.2017.08.004. Epub 2017 Aug 12.
6
Effectiveness of a Multicomponent Intervention to Reduce Multidrug-Resistant Organisms in Nursing Homes: A Cluster Randomized Clinical Trial.多组分干预措施降低疗养院中多重耐药菌效果的:一项群组随机临床试验
JAMA Netw Open. 2021 Jul 1;4(7):e2116555. doi: 10.1001/jamanetworkopen.2021.16555.
7
A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms.一项关于通用戴手套与接触预防措施预防多重耐药菌传播的对照试验。
Am J Infect Control. 2007 Dec;35(10):650-5. doi: 10.1016/j.ajic.2007.02.011.
8
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.法国医护人员对多重耐药菌传播的认知:一项大型横断面调查。
Antimicrob Resist Infect Control. 2019 Nov 12;8:173. doi: 10.1186/s13756-019-0625-0. eCollection 2019.
9
Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 - survey results from the RH(E)IN-CARE network.2019 年法国、德国和瑞士三国交界地区多药耐药菌感染控制和诊断措施的差异 - RH(E)IN-CARE 网络的调查结果。
Swiss Med Wkly. 2021 Mar 1;151:w20454. doi: 10.4414/smw.2021.20454.
10
Impact of psychologically tailored hand hygiene interventions on nosocomial infections with multidrug-resistant organisms: results of the cluster-randomized controlled trial PSYGIENE.心理干预对多药耐药菌医院感染的影响:PSYGIENE 集群随机对照试验的结果。
Antimicrob Resist Infect Control. 2019 Mar 25;8:56. doi: 10.1186/s13756-019-0507-5. eCollection 2019.

引用本文的文献

1
Endocarditis Immunothrombosis.心内膜炎免疫血栓形成
Metabolites. 2025 May 15;15(5):328. doi: 10.3390/metabo15050328.
2
Colonization with extended spectrum beta-lactamase and carbapenemases producing Enterobacteriaceae among hospitalized patients at the global level: A systematic review and meta-analysis.全球住院患者中产超广谱β-内酰胺酶和碳青霉烯酶的肠杆菌科定植情况:系统评价和荟萃分析。
PLoS One. 2023 Nov 27;18(11):e0293528. doi: 10.1371/journal.pone.0293528. eCollection 2023.
3
Host-Bacterium Interaction Mechanisms in Endocarditis: A Systematic Review.

本文引用的文献

1
Differences in infection control and diagnostic measures for multidrug-resistant organisms in the tristate area of France, Germany and Switzerland in 2019 - survey results from the RH(E)IN-CARE network.2019 年法国、德国和瑞士三国交界地区多药耐药菌感染控制和诊断措施的差异 - RH(E)IN-CARE 网络的调查结果。
Swiss Med Wkly. 2021 Mar 1;151:w20454. doi: 10.4414/smw.2021.20454.
2
Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe.分析在欧洲实施指南以防止耐多药革兰氏阴性菌传播所面临的挑战。
BMJ Open. 2019 May 19;9(5):e027683. doi: 10.1136/bmjopen-2018-027683.
3
心内膜炎中宿主-细菌相互作用机制:系统评价。
Int J Mol Sci. 2023 Jul 4;24(13):11068. doi: 10.3390/ijms241311068.
4
Infective Endocarditis in High-Income Countries.高收入国家的感染性心内膜炎
Metabolites. 2022 Jul 25;12(8):682. doi: 10.3390/metabo12080682.
Nation-wide survey of screening practices to detect carriers of multi-drug resistant organisms upon admission to Swiss healthcare institutions.
瑞士全国范围内调查医疗机构入院时对多重耐药菌携带者的筛查实践。
Antimicrob Resist Infect Control. 2019 Feb 13;8:37. doi: 10.1186/s13756-019-0479-5. eCollection 2019.
4
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.耐碳青霉烯类肠杆菌科细菌的流行病学:一种全球威胁的影响与演变
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36. doi: 10.1093/infdis/jiw282.
5
Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital.德国大学医院收治的难民患者、医疗游客和本国患者中多重耐药菌的患病率。
BMC Infect Dis. 2017 Jan 5;17(1):17. doi: 10.1186/s12879-016-2105-y.
6
What's new in multidrug-resistant pathogens in the ICU?重症监护病房中多重耐药病原体有哪些新情况?
Ann Intensive Care. 2016 Dec;6(1):96. doi: 10.1186/s13613-016-0199-4. Epub 2016 Oct 6.
7
Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys.通过连续的现患率调查评估加拿大医院中医院获得性感染的规模和趋势。
Antimicrob Resist Infect Control. 2016 May 21;5:19. doi: 10.1186/s13756-016-0118-3. eCollection 2016.
8
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.碳青霉烯类耐药肠杆菌科感染的治疗选择。
Open Forum Infect Dis. 2015 May 5;2(2):ofv050. doi: 10.1093/ofid/ofv050. eCollection 2015 Apr.
9
Trends and characteristics of attendance at the emergency department of a Swiss university hospital: 2002-2012.瑞士一家大学医院急诊科就诊情况的趋势与特征:2002 - 2012年
Swiss Med Wkly. 2015 May 21;145:w14141. doi: 10.4414/smw.2015.14141. eCollection 2015.
10
Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.法国对新出现的广泛耐药菌(eXDRO)的控制:对来自286家医疗机构的感染预防人员的一项调查。
Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1615-20. doi: 10.1007/s10096-015-2396-8. Epub 2015 May 10.